Fibrinogen, C-reactive protein and coronary heart disease: Does Mendelian randomization suggest the associations are non-causal?

QJM: An International Journal of Medicine

Volumn 97, Issue 3, 2004, Pages 163-166

  Davey Smith, G ^a   Harbord, R ^a   Ebrahim, S ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; BETA CAROTENE; C REACTIVE PROTEIN; FIBRINOGEN; HOMOCYSTEINE;

ARTICLE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENETIC EPIDEMIOLOGY; GENETIC PREDISPOSITION; HUMAN; ISCHEMIC HEART DISEASE; PHENOTYPE; PRIORITY JOURNAL; RANDOMIZATION; RISK FACTOR;

EID: 1542709218     PISSN: 14602725     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/hch025     Document Type: Article

References (9)

1. Kamath S, Lip GYH. Fibrinogen: Biochemistry, epidemiology and determinants. Q J Med 2003; 96:711-29.
2. Hirschfield GM, Pepys MB. C-reactive protein and cardiovascular disease: New insights from an old molecule. Q J Med 2003; 96:793-807.
3. Davey Smith G, Ebrahim S. 'Mendelian randomization': Can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiology 2003; 32:1-22.
4. Youngman LD, Keavney BD, Palmer A, et al. Plasma fibrinogen and fibrinogen genotypes in 4685 cases of myocardial infarction and in 6002 controls: Test of causality by 'Mendelian randomization'. Circulation 2000; 102(suppl. II): 31-2.
5. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin or leucocyte count with coronary heart disease. Meta-analysis of prospective studies. JAMA 1998; 279:1477-82.
6. Brunner E, Davey Smith G, Marmot M, Canner R, Beksinska M, O'Brien J. Childhood social circumstances and psychosocial and behavioural factors as determinants of plasma fibrinogen. Lancet 1996; 347:1008-13.
7. Tybjaerg-Hansen A, Agerholm-Larsen B, Humphries SE, Abildgaard S, Schnohr P, Nordestgaard BG. A common mutation (G455 → A) in the β-Fibrinogen Promoter is an Independent Predictor of Plasma Fibrinogen, but not of Ischaemic Heart Disease. J Clin Invest 1997; 99:3034-9.
8. Zee RYL, Ridker PM. Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis 2001; 162:217-19.
9. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys MB. Low grade inflammation and coronary heart disease: Prospective study and updated meta-analyses. Br Med J 2000; 321:199-204.